A novel use of neoadjuvant crizotinib for a rare ALK-positive endobronchial tumor.
A novel use of neoadjuvant crizotinib for a rare ALK-positive endobronchial tumor.
- 2019
Medicine/Pulmonary/Critical Care
MedStar Georgetown University Hospital Residents
Poster presented at
Medicine/Pulmonary/Critical Care
MedStar Georgetown University Hospital Residents
Poster presented at